Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.


             
 

Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.

Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.

Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.

Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.

Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.



NAVIGATION


         

 

ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced the introduction of a new, narrower size of AQUACEL® and AQUACEL® Ag Ribbon Dressings with Strengthening Fibers, now available in the U.S. and select European countries for the management of moderate to highly exuding chronic and acute wounds…

 

Suneva Medical, a privately-held aesthetic medical device company, announced the publication of interim results from its long-term study on Artefill in the May 2010 issue of Dermatologic Surgery, the Journal of the American Society of Dermatologic Surgery…

 

Changing the hue of hospital gowns and bed sheets to match a patient’s skin color could greatly enhance a physician’s ability to detect cyanosis and other health-related skin color changes, according to a new study from Rensselaer Polytechnic Institute…

 

Canada needs minimum training standards for laser hair removal operators, as currently anyone, trained or not, can legally operate a laser machine for hair removal in Canada, states an editorial in CMAJ (Canadian Medical Association Journal). In Canada, no license is required to operate a laser hair removal machine and training is usually provided by the manufacturer…

 

It is known that fluctuations in the treatment outcome of photodynamic therapy (PDT) between patients are related to the concentration of photosensitizer in target tissue…

 

The National Physical Laboratory (NPL) and the University of Dundee recently assessed the light emitted by a home-use intense-pulsed light (IPL) hair reduction system and confirmed that it is safe. This confirmation is important, as IPL devices must meet the necessary safety guidelines, to ensure users are protected in the case of accidental exposure to the human eye…

 

Suneva Medical, a privately-held aesthetic medical device company, announced that Christopher B. Zachary, MBBS, FRCP, Professor and Chair, Department of Dermatology, University of California, Irvine, presented 18-month interim results from the prospective, open-label, five-year safety and patient satisfaction study on Artefill for nasolabial fold (NLF) correction…

 

PuriCore (LSE:PURI), the life sciences company focused on developing and commercializing proprietary solutions that safely, effectively, and naturally kill infectious pathogens, announced results of a randomized clinical trial showing the potential effectiveness of its Vashe Wound Therapy in the post-operative care of split-thickness skin grafts for burn injuries.

 

The HairDX Genetic Test for Hair Loss, the world’s first genetic baldness (Androgenetic Alopecia) test, is now available as a CE Marked product under the European In Vitro Diagnostic Directive. The announcement was made at the 18th European Academy of Dermatology and Venereology (EADV) Congress in Berlin today by pharmacogenomics research and development innovator PharmaGenoma, Inc. and its subsidiary HairDX Europe, pioneers of

 

Reveal Sciences, LLC, a cosmetics and aesthetics innovation company pioneering breakthrough skin care diagnostics, has announced the launch of the new consumer At-Home Skin Typing and Analysis Kit. Developed by physician Damon Borich, M.D., CEO of Reveal Sciences, and his scientific team, the novel skincare analysis technology is the next-generation spin-off from the company’s professional grade CareTypeTM Analysis System (




September 2010
Mon Tue Wed Thu Fri Sat Sun
« Aug    
 12345
6789101112
13141516171819
20212223242526
27282930